CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Feasibility of stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction
Authors
Amy E. Rettig
AS Braverman
+19Â more
AS Seidman
Charles L. Shapiro
Gary S. Phillips
H Koppler
HJ Lenz
J Quock
JA Sparano
JS Kloover
K Miller
KM Zanotti
Leslie J. Dunlea
M Markman
M Markman
M Morita
MA Bookman
Maryam B. Lustberg
Michael J. Berger
T Sumikawa
WJ Gradishar
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1007%2Fs00520-011-...
Last time updated on 01/04/2019